D-二聚体联合临床决策规则排除癌症患者肺栓塞的安全性及效率:个体患者数据荟萃分析
该个体患者数据荟萃分析纳入17项前瞻性诊断管理研究中的2258例(7.6%)癌症患者,评估Wells评分、修订版Geneva评分和YEARS算法联合D-二聚体排除肺栓塞的失败率与诊断效率。结果显示,排除肺栓塞后3个月静脉血栓栓塞症发生率在各管理类别间相当,范围为0.52%至2.83%;修订版Geneva评分联合年龄调整D-二聚体阈值及YEARS算法的诊断效率最高,达26%。结论认为当前疑似肺栓塞的诊断算法适用于癌症患者。
要点
- 癌症患者使用临床决策规则联合D-二聚体排除肺栓塞后,3个月静脉血栓栓塞症发生率与标准影像学策略相当。
- 修订版Geneva评分联合年龄调整D-二聚体阈值及YEARS算法的诊断效率最高,达26%。
- 当前疑似肺栓塞的诊断算法可适用于癌症患者。
核心结论
- 使用临床决策规则联合D-二聚体排除肺栓塞并避免影像学检查的癌症患者,其失败率与接受标准影像学检查的患者相似。
- 当前疑似肺栓塞的诊断算法适用于癌症患者。
研究设计与样本
- 基于前瞻性诊断管理研究的个体患者数据荟萃分析。
- 共纳入17项研究中的2258例(7.6%)癌症患者。
主要发现
- 排除肺栓塞后3个月静脉血栓栓塞症发生率范围为0.52%(95% CI,0.06%-4.35%)至2.83%(95% CI,0.96%-8.34%),各管理类别间相当。
- 修订版Geneva评分联合年龄调整D-二聚体阈值及YEARS算法的诊断效率最高,为26%。
关键数值与推荐
- 修订版Geneva评分联合年龄调整D-二聚体阈值及YEARS算法的诊断效率为26%。
- 排除肺栓塞后3个月静脉血栓栓塞症发生率最低为0.52%(95% CI,0.06%-4.35%),最高为2.83%(95% CI,0.96%-8.34%)。
临床怎么用
- 对于疑似肺栓塞的癌症患者,可采用Wells评分、修订版Geneva评分或YEARS算法联合D-二聚体进行排除诊断。
- 使用修订版Geneva评分联合年龄调整D-二聚体阈值或YEARS算法可提高诊断效率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Failure rates of clinical decision rules (CDRs) combined with D-dimer to exclude pulmonary embolism (PE) are higher in patients with cancer compared with noncancer patients, raising concerns about their use in this patient group. OBJECTIVES: To compare the failure rates of the Wells score, revised Geneva score, and YEARS algorithm in patients with cancer who underwent standard imaging with those in whom imaging was withheld, and report the diagnostic yield of these algorithms. METHODS: We used data from an individual-patient level meta-analysis of prospective diagnostic management studies of patients with suspected PE. The primary outcome was the 3-month incidence of venous thromboembolism, excluding PE (failure), using fixed and age-adjusted D-dimer results across different patient management categories for all investigated CDRs. The secondary outcome included the proportion of patients for whom PE could be ruled out without further imaging (diagnostic yield). RESULTS: A total of 2258 (7.6%) patients with cancer from 17 studies were included in the analysis. The 3-month incidence of venous thromboembolism in patients after excluding PE ranged from 0.52% (95% CI, 0.06%-4.35%) to 2.83% (95% CI, 0.96%-8.34%) and was comparable across all management categories. The highest diagnostic yield of 26% was found for the revised Geneva score, with an age-adjusted D-dimer cutoff, and the YEARS algorithm. CONCLUSION: The failure rates of patients with cancer for whom PE was excluded using CDRs and withholding imaging were similar to those observed after standard imaging. Current diagnostic algorithms for suspected PE are applicable to patients with cancer.
引用
- Vrotniakaite-Bajerciene K, Mallick R, Takada T, et al. Safety and efficiency of D-dimer testing in combination with clinical decision rules to exclude pulmonary embolism in patients with cancer: individual patient data meta-analysis. J Thromb Haemost. 2025. PMID: 41354153. doi:10.1016/j.jtha.2025.10.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。